1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Pharmaceuticals
Irwin Naturals Inc.

Irwin Naturals Inc.

IWIN.CN
Irwin Naturals Inc.CA flagCanadian Securities Exchange
0.30
CAD
- -
- -
1.02MMarket Cap
Irwin Naturals Inc.
IWIN.CN
(Canadian Securities Exchange)

Recent

price

0.30

P/E

ratio

- -

div

yld

- -

ROIC.AI

2020
2021
2022
TTM
FRC
73.37
83.62
62.51
26.43
Revenue per Share
5.94
7.18
-2.79
-5.89
Basic EPS, GAAP
6.64
9.09
-4.55
-1.97
Free Cash Flow per Basic Share
5.7
6.72
- -
- -
Dividend per Share
- -
14.57
16.18
2.17
Book Value per Share
12.05
19.19
8.67
-0.41
Tangible Book Value per Share
1
1
1
3
Basic Weighted Avg Shares
89
100
89
87
Sales/Revenue/Turnover
8.51
10.53
2.06
-9.03
Operating Margin (%)
1
1
2
2
Depreciation Expense
7
9
-4
-19
Net Income, GAAP
1.58
- -
- -
- -
Effective Tax Rate (%)
8.1
8.59
-4.46
-22.3
Profit Margin (%)
13
15
9
-10
Working Capital
1
2
3
8
LT Debt
15
23
30
14
Total Equity
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
Return on Capital (%)
- -
98.51
-19.64
-124.41
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Mar'23
Jun'23
Sep'23
ST Debt
33
33
33
LT Borrowings
8
7
6
LT Finance Leases
3
2
2
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
3
3
3
Market Capitalization
4
3
3

Working Capital

FRC

•

in mil. unless spec.
Mar'23
Jun'23
Sep'23
Total Current Assets
48
46
38
Cash, Cash Equivalents & STI
7
6
5
Accounts Receivable, Net
16
16
13
Inventories
22
21
17
Total Current Liabilities
49
51
48
Payables & Accruals
13
17
14
ST Debt
33
33
33
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
31.09%
Free Cash Flow
- -
- -
-159.73%
Net Income, GAAP
- -
- -
-146.34%
Sales/Revenue/Turnover
- -
- -
-10.83%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
24
27
24
26
100
2022
23
22
22
23
89
2023
23
22
19
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
3.05
2.44
-1.34
- -
7.18
2022
1.12
0.03
-0.49
- -
-2.79
2023
-2.27
-1.57
-0.56
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
0.9
4.51
1.19
- -
6.72
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
Similar Companies
Ishita Drugs and Industries Limited (ISHITADR.BO)
Desh Rakshak Aushdhalaya Ltd. (DESHRAK.BO)
G-H-3 International Inc. (GHTI)
Alibaba Health Information Technology Limited (ALBBY)
Mind Medicine (MindMed) Inc. (MMCWF)
Kiaro Holdings Corp. (KO.V)
Business
Irwin Naturals Inc. develops, manufactures, and distributes premium vitamins, nutritional supplements, and cannabidiol (CBD) products targeting health and wellness categories including mood and brain function, sleep support, sports performance, sexual health, immune support, weight management, women's health, and men's health; its core offerings comprise over 100 formulas such as liquid soft-gels, gummies, oils, creams, balms, roll-ons, and topicals enhanced by BioPerine Complex for superior absorption and potency, sold under the Irwin Naturals and Nature’s Secret brands through health food stores, mass market retailers, and e-commerce channels across the United States, Canada, and international markets. Founded in 1994 by Klee Irwin and headquartered at 5310 Beethoven Street in Los Angeles, California, the company also operates mental health clinics providing intravenous ketamine infusions for conditions like depression, PTSD, OCD, anxiety, bipolar disorder, migraines, and chronic pain syndromes including CRPS, RSD, and fibromyalgia. In August 2025, substantially all assets of Irwin Naturals Inc. and its affiliates were acquired by FitLife Brands Inc. for $42.5 million in a transaction under Section 363 of the U.S. Bankruptcy Code, funded primarily by a $35.75 million term loan and revolving credit facility from First Citizens Bank with the balance from cash reserves; this deal, which followed a voluntary Chapter 11 reorganization filing in August 2024, doubles FitLife's scale with projected combined annual revenue exceeding $120 million, streamlines operations, boosts e-commerce margins, and accelerates expansion into emerging wellness markets while assuming minimal liabilities.